These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 24565754
1. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms. Dias-Lopes C, Felicori L, Rubrecht L, Cobo S, Molina L, Nguyen C, Galéa P, Granier C, Molina F, Chávez-Olortegui C. Vaccine; 2014 Apr 11; 32(18):2086-92. PubMed ID: 24565754 [Abstract] [Full Text] [Related]
5. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider. Felicori L, Araujo SC, de Avila RA, Sanchez EF, Granier C, Kalapothakis E, Chávez-Olórtegui C. Toxicon; 2006 Oct 01; 48(5):509-19. PubMed ID: 16934304 [Abstract] [Full Text] [Related]
7. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru. Duarte CG, Bonilla C, Guimarães G, Machado de Avila RA, Mendes TM, Silva W, Tintaya B, Yarleque A, Chávez-Olórtegui C. Toxicon; 2015 Jan 01; 93():37-40. PubMed ID: 25448393 [Abstract] [Full Text] [Related]
8. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Barbaro KC, Knysak I, Martins R, Hogan C, Winkel K. Toxicon; 2005 Mar 15; 45(4):489-99. PubMed ID: 15733571 [Abstract] [Full Text] [Related]
9. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms. Ramada JS, Becker-Finco A, Minozzo JC, Felicori LF, Machado de Avila RA, Molina F, Nguyen C, de Moura J, Chávez-Olórtegui C, Alvarenga LM. Toxicon; 2013 Oct 15; 73():47-55. PubMed ID: 23856101 [Abstract] [Full Text] [Related]
10. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies. Guilherme P, Fernandes I, Barbaro KC. Toxicon; 2001 Sep 15; 39(9):1333-42. PubMed ID: 11384721 [Abstract] [Full Text] [Related]
12. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay. Alvarenga LM, Martins MS, Moura JF, Kalapothakis E, Oliveira JC, Mangili OC, Granier C, Chávez-Olórtegui C. Toxicon; 2003 Dec 15; 42(7):725-31. PubMed ID: 14757202 [Abstract] [Full Text] [Related]